VHCP MANAGEMENT II, LLC
Latest 13F filing data - Q4 2019
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | TXG | 1.79M | $136.22M |
 | MRSN | 923K | $5.29M |
 | AXSM | 786K | $81.24M |
 | SPRO | 474K | $4.56M |
 | BHVN | 463K | $25.20M |
 | ADVM | 384K | $4.42M |
 | KALV | 366K | $6.52M |
 | MIST | 149K | $2.38M |
 | RLMD | 115K | $4.48M |
 | ETNB | 41K | $1.08M |
 | NXTC | 36K | $2.04M |
 | PTGX | 32K | $227.00K |
10x Genomics, Inc.
TXG
Shares Held
1.79M
Value
$136.22M
Mersana Therapeutics, Inc.
MRSN
Shares Held
923K
Value
$5.29M
Axsome Therapeutics, Inc.
AXSM
Shares Held
786K
Value
$81.24M
Spero Therapeutics, Inc.
SPRO
Shares Held
474K
Value
$4.56M
Biohaven Ltd.
BHVN
Shares Held
463K
Value
$25.20M
Adverum Biotechnologies, Inc.
ADVM
Shares Held
384K
Value
$4.42M
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
366K
Value
$6.52M
Milestone Pharmaceuticals Inc.
MIST
Shares Held
149K
Value
$2.38M
Relmada Therapeutics, Inc.
RLMD
Shares Held
115K
Value
$4.48M
89bio, Inc.
ETNB
Shares Held
41K
Value
$1.08M
NextCure, Inc.
NXTC
Shares Held
36K
Value
$2.04M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
32K
Value
$227.00K